NMES-BCI for Motor Disorders

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
The University of Texas at Austin, Austin, TXMotor Disorders+10 MoreNMES-BCI - Device
Eligibility
18 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether or not a brain-computer interface (BCI) can help people with low spatial resolution differentiate patterns of activity associated with different hand movements of the same limb.

Eligible Conditions
  • Motor Disorders
  • Muscular Dystrophy
  • Motor Neuron Disease
  • Healthy Subjects
  • Stroke
  • Spinal Cord Injury
  • Traumatic Brain Injury
  • Movement Disorders

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: Difference between the week before versus after each intervention

Difference between the week before versus after each intervention
Change in fMRI activation for different imagined movements
Change in the BCI command delivery accuracy
Changes in electroencephalography functional connectivity
Changes in motor-evoked potential amplitude
Stability and separability of Motor Imagery features

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Visual-BCI
1 of 2
NMES-BCI
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: NMES-BCI · No Placebo Group · N/A

NMES-BCI
Device
Experimental Group · 1 Intervention: NMES-BCI · Intervention Types: Device
Visual-BCI
Device
ActiveComparator Group · 1 Intervention: Visual-BCI · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: difference between the week before versus after each intervention

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
297 Previous Clinical Trials
67,898 Total Patients Enrolled
Jose del R. Millan, PhDPrincipal InvestigatorThe University of Texas at Austin
1 Previous Clinical Trials
32 Total Patients Enrolled

Eligibility Criteria

Age 18 - 80 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have difficulty moving due to conditions such as stroke, spinal cord injury, or muscular disease. You also have pain, movement disorders, or brain-related conditions that affect your motor skills. You need to have normal or corrected vision and be able to read and understand English. Finally, you must be able to provide informed consent.

Who else is applying?

What state do they live in?
Texas100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
The University of Texas at Austin100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

Frequently Asked Questions

Does this medical research accept applicants over the age of fifty-five?

"This trial requires that applicants are aged between 18 and 80. For younger participants, there are 511 clinical trials available while those 65 years or older can choose from 2,937 studies." - Anonymous Online Contributor

Unverified Answer

Does my profile qualify me to participate in this research study?

"This investigation is accepting 40 people with a stroke between 18 - 80 years of age. To be eligible, subjects must have motor deficits resulting from unilateral/bilateral stroke, spinal cord injury, motor neuron diseases (e.g., amyotrophic lateral sclerosis or multiple sclerosis), muscular disorders (myopathy), traumatic pain/neurological pain, movement issues (cerebral palsy) due to orthopedic trauma or brain tumors; they also need to possess normal vision and general good health as well as having no prior neurological or psychiatric ailments. Moreover, applicants should comprehend English since Research Personnel do not converse in Spanish and are" - Anonymous Online Contributor

Unverified Answer

Is it currently possible for participants to join this clinical investigation?

"Per clinicaltrials.gov, this trial is not currently seeking patients. Initially posted on June 16th 2021 and most recently adjusted November 17th 2022, the study has suspended recruitment for now - though 3976 other trials remain open to participants at this moment in time." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.